IL189248A0 - Use of tiotropium salts in the treatment of severe persistant asthma - Google Patents

Use of tiotropium salts in the treatment of severe persistant asthma

Info

Publication number
IL189248A0
IL189248A0 IL189248A IL18924808A IL189248A0 IL 189248 A0 IL189248 A0 IL 189248A0 IL 189248 A IL189248 A IL 189248A IL 18924808 A IL18924808 A IL 18924808A IL 189248 A0 IL189248 A0 IL 189248A0
Authority
IL
Israel
Prior art keywords
treatment
tiotropium salts
asthma
severe
persistant asthma
Prior art date
Application number
IL189248A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35432680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL189248(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL189248A0 publication Critical patent/IL189248A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL189248A 2005-08-06 2008-02-04 Use of tiotropium salts in the treatment of severe persistant asthma IL189248A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05107266 2005-08-06
PCT/EP2006/064958 WO2007017438A1 (en) 2005-08-06 2006-08-02 Use of tiotropium salts in the treatment of severe persistant asthma

Publications (1)

Publication Number Publication Date
IL189248A0 true IL189248A0 (en) 2008-08-07

Family

ID=35432680

Family Applications (1)

Application Number Title Priority Date Filing Date
IL189248A IL189248A0 (en) 2005-08-06 2008-02-04 Use of tiotropium salts in the treatment of severe persistant asthma

Country Status (16)

Country Link
US (3) US20070032516A1 (OSRAM)
EP (1) EP1915158A1 (OSRAM)
JP (1) JP2009504604A (OSRAM)
KR (1) KR20080039974A (OSRAM)
CN (1) CN101237872A (OSRAM)
AR (1) AR055597A1 (OSRAM)
AU (1) AU2006277968A1 (OSRAM)
BR (1) BRPI0614394A2 (OSRAM)
CA (1) CA2617717C (OSRAM)
IL (1) IL189248A0 (OSRAM)
MX (1) MX2008001506A (OSRAM)
NZ (1) NZ566399A (OSRAM)
RU (1) RU2422144C2 (OSRAM)
TW (1) TWI409072B (OSRAM)
WO (1) WO2007017438A1 (OSRAM)
ZA (1) ZA200800186B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250426B2 (en) 2002-11-29 2007-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Tiotropium-containing pharmaceutical combination for inhalation
EP1971332B1 (en) * 2006-01-04 2011-03-09 Boehringer Ingelheim International GmbH Use of tiotropium salts in the treatment of moderate persistent asthma
ES2533535T3 (es) * 2009-11-17 2015-04-10 Cipla Limited Soluciones para inhalación
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US5888396A (en) * 1996-12-17 1999-03-30 Perriello; Felix Anthony Bioremediation of pollutants with butane-utilizing bacteria
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
IL155335A0 (en) * 2000-10-12 2003-11-23 Boehringer Ingelheim Pharma Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
CN1674918A (zh) * 2002-06-12 2005-09-28 埃匹吉尼斯医药有限公司 利用脱氢表雄酮甾体及抗毒蕈碱药物治疗呼吸道疾病及肺病的组合物、制剂和试剂盒
NZ538493A (en) * 2002-08-29 2007-10-26 Cipla Ltd Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
EP1896607A4 (en) * 2005-05-10 2009-12-16 Synergenz Bioscience Ltd METHOD AND COMPOSITIONS FOR THE ASSESSMENT OF LUNG FUNCTION AND RESPIRATORY DISEASE
US7933722B2 (en) * 2005-05-20 2011-04-26 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
EP1971332B1 (en) 2006-01-04 2011-03-09 Boehringer Ingelheim International GmbH Use of tiotropium salts in the treatment of moderate persistent asthma

Also Published As

Publication number Publication date
CA2617717C (en) 2014-02-11
RU2422144C2 (ru) 2011-06-27
ZA200800186B (en) 2009-04-29
CA2617717A1 (en) 2007-02-15
EP1915158A1 (en) 2008-04-30
TW200744606A (en) 2007-12-16
NZ566399A (en) 2011-07-29
AR055597A1 (es) 2007-08-29
US20070032516A1 (en) 2007-02-08
RU2008108302A (ru) 2009-09-20
AU2006277968A1 (en) 2007-02-15
US20130245059A1 (en) 2013-09-19
WO2007017438A1 (en) 2007-02-15
KR20080039974A (ko) 2008-05-07
TWI409072B (zh) 2013-09-21
BRPI0614394A2 (pt) 2011-03-29
JP2009504604A (ja) 2009-02-05
CN101237872A (zh) 2008-08-06
MX2008001506A (es) 2008-04-07
US20090163531A1 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
HUS1700015I1 (hu) PDGFR-alfa elleni antitest és alkalmazása tumorok kezelésénél
IL186616A (en) Spyro-oxa-indoles and their use as drugs
IL191317A (en) Use of cells for the preparation of a pharmaceutical preparation for complementary treatment
GB0625659D0 (en) Therapeutic compounds and their use
IL182010A0 (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases
HUE037109T2 (hu) Endoxifén rák kezelésében történõ alkalmazásra
IL178816A0 (en) The treatment of childhood asthma
IL199168A0 (en) Indolizine derivatives and the use thereof as antidiabetics
IL188178A0 (en) Pure and stable tiotropium bromide
IL189248A0 (en) Use of tiotropium salts in the treatment of severe persistant asthma
IL199214A0 (en) New combination for use in the treatment of inflammatory disorders
EP1757282A4 (en) USE OF KAURANE COMPOUNDS IN THE MANUFACTURE OF MEDICAMENTS
IL192602A0 (en) Use of tiotropium salts in the treatment of moderate persistent asthma
GB0506835D0 (en) Therapeutic use of nefopam
GB0415181D0 (en) Compounds for use in the treatment of infection
IL185575A0 (en) Benzoxazocines and their therapeutic use
GB0501655D0 (en) Therapeutic use
GB0622479D0 (en) Novel salts and their therapeutic use
GB0515703D0 (en) Therapeutic use of nefopam
GB0526292D0 (en) A composition for use in the treatment of a surface
GB2437458B (en) Game machine and self-running body for use therein
GB0516610D0 (en) Compounds for use in therapy
EP1956001A4 (en) PHARMACEUTICAL PRODUCT FOR USE IN THE TREATMENT OF URETEROLITHIASE
HK1119954A (en) Use of neboglamine in the treatment of toxicodependency
GB0614538D0 (en) Therapeutic Compounds And Their Use